Braskem Reports Improved Q1 EBITDA Amidst High Leverage and Significant Cash Burn

summarizeSummary

Braskem reported a 76% quarter-over-quarter increase in recurring EBITDA for Q1 2026, reaching US$192 million, but continues to face severe financial challenges including 16.81x corporate leverage and R$5.04 billion in total cash consumption.

check_boxKey Events

• Improved Q1 Recurring EBITDA

  Reported US$192 million in recurring EBITDA for 1Q26, a 76% increase compared to 4Q25, indicating operational recovery.

• High Corporate Leverage

  Corporate leverage reached an extremely high 16.81x, with Adjusted Net Debt at US$8.5 billion as of March 31, 2026.

• Significant Cash Consumption

  Experienced R$3.169 billion in recurring cash consumption and R$5.039 billion in total cash consumption during 1Q26.

• Alagoas Case Update

  Work on the Alagoas geological event continues to advance, with a net balance of R$3.4 billion in provisions as of March 2026, though future costs remain uncertain.

auto_awesomeAnalysis

This 6-K provides the first quarterly financial update following Braskem's disclosure of massive 2025 losses and consideration of judicial reorganization. While the significant improvement in recurring EBITDA offers a glimmer of operational recovery, the company's financial stability remains highly precarious due to extremely high corporate leverage of 16.81x and substantial cash consumption. Investors will closely watch whether operational improvements can translate into a stronger balance sheet and reduced debt, especially given the ongoing uncertainty surrounding the Alagoas provisions and the company's distressed credit ratings.